Fangfei Chen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Endoscopic Submucosal Dissection

Helicobacter Pylori

Top Venues

The American journal of gastroenterology

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Qianjun Zhuang, Song Feng Chen, Xuyu Zhou, Xingyu Jia, Meng Yu Zhang, Nian Di Tan, Fangfei Chen, Zhanye Zhang, Junnan Hu, Yinglian Xiao
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis. The American journal of gastroenterology (2024)
Qianjun Zhuang, Song Feng Chen, Xuyu Zhou, Xingyu Jia, Meng Yu Zhang, Nian Di Tan, Fangfei Chen, Zhanye Zhang, Junnan Hu, Yinglian Xiao
Comparative efficacy of P-CABs versus proton pump inhibitors for Grade C/D esophagitis: A systematic review and network meta-analysis. The American journal of gastroenterology (2024)
Qianjun Zhuang, Song Feng Chen, Xuyu Zhou, Xingyu Jia, Meng Yu Zhang, Nian Di Tan, Fangfei Chen, Zhanye Zhang, Junnan Hu, Yinglian Xiao
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis. The American journal of gastroenterology 119 (5) (2024)
Qianjun Zhuang, Song Feng Chen, Xuyu Zhou, Xingyu Jia, Meng Yu Zhang, Nian Di Tan, Fangfei Chen, Zhanye Zhang, Junnan Hu, Yinglian Xiao
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis. The American journal of gastroenterology 119 (5) (2024)
Qianjun Zhuang, Song Feng Chen, Xuyu Zhou, Xingyu Jia, Meng Yu Zhang, Nian Di Tan, Fangfei Chen, Zhanye Zhang, Junnan Hu, Yinglian Xiao
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis. The American journal of gastroenterology 119 (5) (2024)
Yali Du, Yuzhou Huang, Wenzhe Zhou, Xinjian Liu, Fangfei Chen, Chen Yang, Miao Chen, Jing Ruan, Bing Han
Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study. Drug design, development and therapy 14 (2020)